TRANSFORMING GROWTH-FACTOR-ALPHA AND CD68 IMMUNOREACTIVITY IN GIANT-CELL TUMORS OF BONE - A STUDY ON THE NATURE OF STROMAL AND GIANT-CELLS,AND THEIR INTERRELATIONS
T. Hasegawa et al., TRANSFORMING GROWTH-FACTOR-ALPHA AND CD68 IMMUNOREACTIVITY IN GIANT-CELL TUMORS OF BONE - A STUDY ON THE NATURE OF STROMAL AND GIANT-CELLS,AND THEIR INTERRELATIONS, Journal of pathology, 170(3), 1993, pp. 305-310
To clarify the nature of neoplastic cells, 17 giant cell tumours of bo
ne were studied histologically and immunohistochemically. L1 antigen a
nd S-100 protein were not detected in the tumour giant cells and strom
al cells, although present in non-neoplastic macrophages. The giant ce
lls in all the lesions, some stromal cells, and osteoclasts in the nor
mal bone showed CD68 and transforming growth factor alpha (TGFalpha) i
mmunoreactivity. Fibrohistiocytic antigen, factor XIIIa, was expressed
in large numbers of stromal cells in all lesions. Some stromal cells
expressed alpha-smooth muscle actin and osteocalcin. These immunohisto
chemical results suggested that the stromal cells of giant cell tumour
s of bone showed histiocytic and occasional myofibroblastic and osteob
lastic differentiation. Proliferating cell nuclear antigen was demonst
rated in the nuclei of the stromal cells only, indicating that these w
ere the sole proliferating elements. TGFalpha produced by the giant ce
lls and some stromal cells may play a role as a mediator for the attra
ction and/or proliferation of the precursor cells, and may suppress th
e activity of osteoblastic stromal cells, resulting in restricted bone
formation in giant cell tumours.